Asian Tiger States' Drug Market Growth
The pharmaceutical markets of the emerging "Tiger States" of Asia, led by India, Indonesia, Pakistan, South Korea, Taiwan and Thailand, experienced joint overall growth of 13.6% in dollar terms in 1994, which is nearly double the 7.6% growth reported for the world pharmaceutical market during the year, according to new data published by PMSI International.
The Tiger States currently account for more than 7% of the world drug market, and their retail, institutional and over-the-counter drug markets grew faster than any other region of the world during 1994. However, they are highly fragmented, with the largest pharmaceutical corporations accounting for only 28% of total sales throughout the region.
Percentage of Retail, Institutional and OTC Pharma Market of Tiger States by Corporation Corporation 1994 Year on Year Market Share Growth Glaxo 1.86% 15.1% Hoechst 1.71% 17.0% Dong A 1.24% 20.3% Pfizer 1.20% 24.2% SB 0.91% 15.7% Source: PMSI
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze